HSA — authorised 23 December 2019
- Marketing authorisation holder: ALLERGAN
- Status: likely_approved
HSA authorised Ubrelvy on 23 December 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 23 December 2019.
ALLERGAN holds the Singaporean marketing authorisation.